Navigation Links
Statement of Ben Anderson, Esq., Regarding Denial of Wyeth's En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Date:10/15/2010

CINCINNATI, Oct. 15/PRNewswire-USNewswire/ --  "This is a significant decision in a case being watched very closely by regulators, patient advocates and the entire pharmaceutical industry," commented Benjamin H. Anderson, Esq. "We strongly believe arguments were made that an en banc hearing was not necessary and that the three-judge panel had acted correctly in reinstating the plaintiff's claim that the diet drug Redux (commonly known as fen-phen) should never have been marketed to the American people."

Wyeth's en banc petition came after the Sixth Circuit Court of Appeals in August rejected Wyeth's claim that Federal drug regulations preempt Ohio negligence claims. Anderson noted that the case (Oliver Wimbush v. Wyeth et al., # 09-3380) was one of the first to be heard following the U.S. Supreme Court's landmark preemption ruling in Wyeth v. Levine. His firm, Anderson Law Offices, LLC, Cleveland, Ohio, is counsel for the plaintiff.


'/>"/>
SOURCE Anderson Law Offices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cellectis Publishes Its Financial Statement for the First Half of 2010
2. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
3. Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine
4. Statement from CHPA on Todays FDA Advisory Committee Meeting on Dextromethorphan
5. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
6. Statement from Eli Lilly and Company Regarding Approval Recommendation from FDA Advisory Committee for Expanding the Pain Indications for Cymbalta® to a Broader Pain Population
7. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
8. NCPA Statement on CVS Caremark-Aetna Agreement
9. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
10. Dendreon Statement on CMS National Coverage Analysis
11. NORD Calls for Statement of Policy on Orphan Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Ischemic Stroke ...  report to their offering.       ... Global Acute Ischemic Stroke Market and ... into Acute Ischemic Stroke pipeline products, Acute ...
(Date:5/3/2016)... 2016 Global Insulin Needles ... 09 key companies and supported with 272 tables ... study on the current state of the Insulin ... industry including definitions, classifications, applications and industry chain ... for the international market including development history, competitive ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, an ... rheumatic fever, which damaged his heart. He continued enjoying ... by June 2013, Shepherd,s heart was giving out and ... On June 20, 2013, the Mesa, Arizona ... Heart (TAH-t). Like a heart transplant, the SynCardia TAH-t ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... Dallas, Texas (PRWEB) , ... May 04, 2016 , ... ... cancer awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging ... heed dermatology experts’ advice and focus on skin safety and health now and in ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals ... cellular and metabolic health. This synergistic combination of omega-3 fatty acids and potent ... 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , ...
Breaking Medicine News(10 mins):